Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Penile cancer

Welcome changes in disease management and remaining challenges

Achieving the best possible practice in the management of patients with penile cancer is hampered by a lack of evidence owing to the rare occurrence of this disease. New population-based data from the USA show improved surgical and medical practice patterns but also highlight challenges in providing optimum care to all patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mossanen, M., Holt, S., Gore, J. L., Lin, D. W. & Wright, J. L. 15 years of penile cancer management in the United States: an analysis of the use of partial penectomy for localized disease and chemotherapy in the metastatic setting. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2016.06.019 (2016).

  2. Sri, D. et al. The significance of close surgical margins in organ sparing surgery for penile squamous cell cancer [abstract 4]. J. Clin. Urol. 9 (Suppl.), 10 (2016).

    Google Scholar 

  3. Osinibi, E. et al. Patient reported outcomes of glans resurfacing for penile lichen sclerosis and malignancy [abstract P99]. BJU Int. 115 (Suppl. 7), 56 (2015).

    Google Scholar 

  4. Nicholson, S. et al. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001). Br. J. Cancer 109, 2554–2559 (2013).

    Article  CAS  Google Scholar 

  5. Djajadiningrat, R. S., Bergman, A. M., van Werkhoven, E., Vegt, E. & Horenblas, S. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer. Clin. Genitourin. Cancer 13, 44–49 (2015).

    Article  Google Scholar 

  6. Leijte, J. A. et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur. Urol. 54, 161–168 (2008).

    Article  Google Scholar 

  7. Hakenberg, O. W. et al. EAU guidelines on penile cancer: 2014 update. Eur. Urol. 67, 142–150 (2015).

    Article  Google Scholar 

  8. Ayres, B. et al. Recent trends in incidence and mortality of penile cancer in England [abstract 1052]. Eur. Urol. Suppl. 6, 285 (2007).

    Article  Google Scholar 

  9. Torbrand, C. et al. Socioeconomic factors and penile cancer risk and mortality; a population-based study. BJU Int. http://dx.doi.org/10.1111/bju.13534 (2016).

  10. Nicholson, S., Kayes, O. & Minhas, S. Clinical trial strategy for penis cancer. BJU Int. 113, 852–853 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

B.A. researched data for the article and wrote the manuscript. Both authors made a substantial contribution to discussion of content and reviewed and/or edited the manuscript before submission.

Corresponding author

Correspondence to Ben Ayres.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ayres, B., Watkin, N. Welcome changes in disease management and remaining challenges. Nat Rev Urol 13, 637–639 (2016). https://doi.org/10.1038/nrurol.2016.204

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.204

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing